REGULUS THERAPEUTICS INC (RGLS)

US75915K3095 - Common Stock

2.44  -0.08 (-3.17%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.0010.01M6.83M
Operating Expenses
31.11M28.24M27.82M24.16M23.67M
Research and Development
21.01M18.31M17.35M14.90M11.78M
Selling, General, and Administrative Expenses
9.96M9.83M10.02M8.81M11.32M
Operating Income
-31.11M-28.24M-27.82M-14.16M-16.83M
Interest Income/Expense
1.07M-80.00K10.00K-1.58M-1.76M
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-30.04M-28.32M-27.81M-15.73M-18.59M
Income Tax
1.00K0.000.000.000.00
Net Income
-30.04M-28.32M-27.81M-15.73M-18.59M
EBITDA
-30.88M-28.12M-27.36M-13.69M-15.90M
 
Per Share Data
EPS Diluted Total Ops
-1.58-1.86-3.24-4.50-10.74
Non GAAP EPS
-1.59-1.90-3.30-5.50-11.00
 
Statistics
Profit Margin
N/AN/AN/A-157.14%-272.18%
Operating Profit Margin
N/AN/AN/A-141.46%-246.41%

All data in USD

Charts